Morgan Stanley Call 170 MRK 19.12.../ DE000MG4DNF5 /
2024-08-09 5:52:12 PM | Chg.-0.007 | Bid8:02:54 PM | Ask8:02:54 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.182EUR | -3.70% | 0.186 Bid Size: 50,000 |
0.190 Ask Size: 50,000 |
Merck and Co Inc | 170.00 USD | 2025-12-19 | Call |
GlobeNewswire
06-11
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire
06-06
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire
05-28
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
05-23
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
05-16
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-14
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
05-08
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
04-24
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire
04-15
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness